The mechanisms of action of metformin

Graham Rena, D. Grahame Hardie (Lead / Corresponding author), Ewan R. Pearson

Research output: Contribution to journalReview article

375 Citations (Scopus)
333 Downloads (Pure)

Abstract

Metformin is a widely-used drug that results in clear benefits in relation to glucose metabolism and diabetes-related complications. The mechanisms underlying these benefits are complex and still not fully understood. Physiologically, metformin has been shown to reduce hepatic glucose production, yet not all of its effects can be explained by this mechanism and there is increasing evidence of a key role for the gut. At the molecular level the findings vary depending on the doses of metformin used and duration of treatment, with clear differences between acute and chronic administration. Metformin has been shown to act via both AMP-activated protein kinase (AMPK)-dependent and AMPK-independent mechanisms; by inhibition of mitochondrial respiration but also perhaps by inhibition of mitochondrial glycerophosphate dehydrogenase, and a mechanism involving the lysosome. In the last 10 years, we have moved from a simple picture, that metformin improves glycaemia by acting on the liver via AMPK activation, to a much more complex picture reflecting its multiple modes of action. More work is required to truly understand how this drug works in its target population: individuals with type 2 diabetes.
Original languageEnglish
Pages (from-to)1577-1585
Number of pages9
JournalDiabetologia
Volume60
Issue number9
Early online date3 Aug 2017
DOIs
Publication statusPublished - Sep 2017

Keywords

  • AMPK
  • Biguanide
  • Diabetes
  • Metformin

Fingerprint Dive into the research topics of 'The mechanisms of action of metformin'. Together they form a unique fingerprint.

  • Projects

    Cite this